Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation

被引:39
作者
Chemaitilly, W.
Boulad, F.
Heller, G.
Kernan, N. A.
Small, T. N.
O'Reilly, R. J.
Sklar, C. A.
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York Presbyterian Hosp, Dept Pediat, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
关键词
childhood cancer survivors; stem cell transplantation; growth; final height;
D O I
10.1038/sj.bmt.1705694
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Impaired linear growth has been shown to occur in individuals treated during childhood with single-dose and fractionated total body irradiation (TBI) before stem cell transplantation. Our objective was to describe the final heights attained and patient/treatment factors correlating with final height in a cohort of childhood cancer survivors treated with hyperfractionated TBI (total dose 1375 or 1500 cGy). Thirty individuals (18 men) were included in the study. The mean final height standard deviation score (s.d.s.) was -1.9 +/- 0.2, significantly lower than height s.d.s. at TBI (-0.2 +/- 0.2, P < 0.001). Final height s.d.s. was significantly correlated with age at diagnosis, age at TBI and target height (P=0.04, P < 0.001, P < 0.001, respectively). Treatment with growth hormone (GH) (n = 7) maintained mean height s.d.s. at -2.0 from the onset of GH therapy until attainment of final height. The mean final sitting height s.d.s. was -2.2 +/- 0.2 (n 16), significantly shorter than mean final standing height s.d.s. (P < 0.01). In conclusion, treatment with hyperfractionated TBI is associated with a reduction in standing height and an even greater reduction in sitting height. Final height after hyperfractionated TBI was similar to that reported after fractionated TBI.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 30 条
[1]  
BAKER HWG, 1970, LANCET, V2, P1193
[2]   Patterns of growth and body proportions after total-body irradiation and hematopoietic stem cell transplantation during childhood [J].
Bakker, B ;
Oostdijk, W ;
Geskus, RB ;
Stokvis-Brantsma, WH ;
Vossen, JM ;
Wit, JM .
PEDIATRIC RESEARCH, 2006, 59 (02) :259-264
[3]   Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies [J].
Bakker, B ;
Massa, GG ;
Oostdijk, W ;
Van Weel-Sipman, MH ;
Vossen, JM ;
Wit, JM .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (1-2) :31-37
[4]   TABLES FOR PREDICTING ADULT HEIGHT FROM SKELETAL AGE - REVISED FOR USE WITH THE GREULICH-PYLE HAND STANDARDS [J].
BAYLEY, N ;
PINNEAU, SR .
JOURNAL OF PEDIATRICS, 1952, 40 (04) :423-441
[5]   GROWTH AND GROWTH-HORMONE SECRETION AFTER BONE-MARROW TRANSPLANTATION [J].
BRAUNER, R ;
FONTOURA, M ;
ZUCKER, JM ;
DEVERGIE, A ;
SOUBERBIELLE, JC ;
PREVOTSAUCET, C ;
MICHON, J ;
GLUCKMAN, E ;
GRISCELLI, C ;
FISCHER, A ;
RAPPAPORT, R .
ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 68 (04) :458-463
[6]   Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation [J].
Brauner, R ;
Adan, L ;
Souberbielle, JC ;
Esperou, H ;
Michon, J ;
Devergie, A ;
Gluckman, E ;
Zucker, JM .
JOURNAL OF PEDIATRICS, 1997, 130 (05) :785-792
[7]   ALLOGENEIC BONE-MARROW TRANSPLANTATION AFTER HYPERFRACTIONATED TOTAL-BODY IRRADIATION AND CYCLOPHOSPHAMIDE IN CHILDREN WITH ACUTE-LEUKEMIA [J].
BROCHSTEIN, JA ;
KERNAN, NA ;
GROSHEN, S ;
CIRRINCIONE, C ;
SHANK, B ;
EMANUEL, D ;
LAVER, J ;
OREILLY, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (26) :1618-1624
[8]  
ClementDeBoers A, 1996, J PEDIATR-US, V129, P544
[9]  
Cohen A, 1999, BLOOD, V93, P4109
[10]   Final height and gonad function after total body irradiation during childhood [J].
Couto-Silva, A-C ;
Trivin, C. ;
Esperou, H. ;
Michon, J. ;
Baruchel, A. ;
Lemaire, P. ;
Brauner, R. .
BONE MARROW TRANSPLANTATION, 2006, 38 (06) :427-432